Christoph BACRI

Dr. Christoph BACRI

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2024 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
CBChristoph BACRI
Christoph BACRI
KHKheira Hireche
Kheira Hireche
PAPierre Alric
Pierre Alric
LCLudovic Canaud
Ludovic Canaud

4 December 2023 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
CBChristoph BACRI
Christoph BACRI
BOBaris Ata Ozdemir
Baris Ata Ozdemir
KHKheira Hireche
Kheira Hireche
PAPierre Alric
Pierre Alric
LCLudovic Canaud
Ludovic Canaud
Objective: The aim of this study is to report the efficiency and safety of single-fenestrated physician-modified endografts (PMEGs) in zone 2 aortic arch pathologies with at least 3 years of follow-up. Methods: All consecutive patients with a pathological aortic arch who underwent aortic repair combined with homemade single-fenestrated stent-graft from 2015 to 2020 were reviewed. The patients with a target vessel different from the left subclavian artery (LSA) were excluded. Results: A total of 63 patients were treated for a pathological arch in zone 2 with a single-fenestrated PMEG. 73% were male, and the mean age was 65 years old. 25% were treated for a degenerative aneurysm, 19% for a post dissection aneurysm and 24% for an acute type B dissection. 52% of the patients were treated as an emergency and half of those for an aortic rupture. The LSA fenestration was stented in 70%. During 30 days of follow-up, 2 strokes (3%) were reported, 6 patients (10%) died with 4 of those treated for aortic rupture and 1 had a retrograde aortic dissection. During at least 3 years of follow-up (median 49 months), no reintervention was needed for endoleaks, there was no stent fracture or stent migration. No patient died from an aortic cause. Subgroup analysis comparing the endovascular treatment for various aortic pathologies did not find significant differences in death rate or comorbidity including stroke. When comparing emergent and elective aortic repair, operating time was similar (64 vs 65 minutes), and the LSA fenestration was less frequently stented (52%) in the emergency group. There was no difference in stroke frequency. There was a higher rate of death in the emergency group at 30 days of follow-up, but no patient died from aortic cause in the long-term follow-up. Conclusions: Aortic arch repair with single-fenestrated PMEGs for zone 2 pathological arch disease is associated with acceptable early and midterm major morbidity and mortality. It is suitable for emergency situations. Clinical Impact: Single-fenestrated PMEG for the left subclavian artery is a safe and efficient option in the short and medium term for the treatment of the aortic arch in zone 2 with 98% technical success. It allows for aortic repair and subclavian artery revascularization in a single step for all patients. It is suitable for a range of main pathologies, including degenerative, dissection-related, isthmus rupture, and embolic pathologies. Additionally, it is always available and easily utilized in emergency cases.

7 December 2024 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
CBChristoph BACRI
Christoph BACRI
KHKheira Hireche
Kheira Hireche
PAPierre Alric
Pierre Alric
LCLudovic Canaud
Ludovic Canaud
Objective: Endovascular aortic arch repair is an emerging procedure for all aortic pathologies, not only in high-risk patients. Little is known about the association between the type of anesthesia and outcomes. The aim of this study is to demonstrate the feasibility on short-term clinical outcomes of patients undergoing total aortic arch repair with double-fenestrated physician-modified endografts (PMEGs) under local anesthesia with sedation (also known as monitored anesthesia care [MAC]). Methods: From January to May 2024, data were prospectively collected on all procedures for total aortic arch repair with double-fenestrated PMEGs. Exclusion criteria were general anesthesia (GA). Study endpoints were technical success, time spent in the operating room, hospital stay, 30-day mortality, short-term complications, and re-interventions, according to the type of anesthesia. Results: Between January and May 2024, prospective data were collected on 20 procedures at a single referral center. A total of 14 procedures were performed under MAC. Technical success was 100%. In total, 71% of the patients were treated electively, and all major aortic pathologies were encountered (aneurysm, acute and chronic dissection, trauma, etc). In total, 93% of the procedures were done totally percutaneously, and MAC was no limitation for femoral surgical cutdown. No conversions from MAC to GA were necessary. The mean procedure time was 54 minutes (range=29-108 minutes). At 30 days follow-up, there were no major endoleaks, stent occlusions, or graft migrations. No patient died or experienced stroke. One patient had an asymptomatic retrograde dissection discovered on the follow-up computed tomography (CT) scan at 1 month requiring open surgical replacement. There were no cases of acute lung, myocardial, bowel, or kidney injury. The mean hospital stay was 4.9 days (range=2-23 days) and the mean intensive care unit (ICU) stay was 1.1 days (range=0-23 days). Conclusion: Endovascular total aortic arch repair with double-fenestrated PMEGs is feasible under local anesthesia with sedation. The short-term outcomes in a small patient cohort are promising for the development of MAC in aortic arch repair. Clinical Impact: The outcomes of local anesthesia and sedation (also referred to as monitored anesthesia care) in endovascular aortic arch repair are not well-studied or widely reported. This study aims to demonstrate the feasibility and safety of this approach using physician-modified endografts for total aortic arch repair and showing it is a promising alternative to general anesthesia. Only a few exclusion criteria necessitate performing the procedure under general anesthesia and no conversions to general anesthesia were required.

7 August 2024 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
CBChristoph BACRI
Christoph BACRI
KHKheira Hireche
Kheira Hireche
PAPierre Alric
Pierre Alric
LCLudovic Canaud
Ludovic Canaud

27 September 2023 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
CBChristoph BACRI
Christoph BACRI
RCRobin Chastant
Robin Chastant
LCLucien Chassin-Trubert
Lucien Chassin-Trubert
KHKheira Hireche
Kheira Hireche
PAPierre Alric
Pierre Alric
LCLudovic Canaud
Ludovic Canaud
Objective: The aim of this case series is to report feasibility, efficiency, and safety of fenestrated physician-modified endografts (PMEGs) in aortic arch pathologies with aberrant right subclavian artery (ARSA) and/or Kommerell’s diverticulum (KD). Methods: All consecutive patients with ARSA and/or KD who underwent hybrid aortic arch repair combined with homemade fenestrated stent-graft from 2018 to 2022 were reviewed. Results: Six patients with ARSA and/or KD underwent hybrid surgery for aortic repair, 4 of whom were men, with a mean age of 49 years. Furthermore, 2 of them were symptomatic with dysphagia, 1 was taken in emergency, 1 had a bovine arch and a KD, and 2 had right descending thoracic aortas. The mean operation time was 138 (111–216) minutes. In addition, 83% of the homemade grafts were double fenestrated. All the proximal landings were in zone 0; the mean proximal aortic diameter was 29 (23–34) mm. The range of diameters for the endografts were 24 to 38 mm. There was a 100% technical success, with 0% 30 days mortality, no stroke, and no endoleak. During the follow-up, no aortic-related death or secondary intervention was required and all supra-aortic vessels remain patent. Conclusion: Hybrid aortic arch repair, with fenestrated PMEGs for ARSA and/or KD, is associated with acceptable early and midterm major morbidity and mortality. Clinical Impact: This retrospective case series analyzed outcomes in 6 patients with an aberrant right subclavian artery and/or Kommerell’s diverticulum treated with fenestrated PMEGs during an average 16 month follow-up. The case series suggests that the use of these fenestrated PMEGs for the management of patients with an aberrant right subclavian artery is a safe, effective and durable method in the medium-term.

3 January 2026 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
CBChristoph BACRI
Christoph BACRI
KHKheira Hireche
Kheira Hireche
PAPierre Alric
Pierre Alric
LCLudovic Canaud
Ludovic Canaud
Objective: To assess the impact of selective supra-aortic trunk (SAT) stenting on aortic remodeling in patients with chronic type A aortic dissection (cTAAD). Methods: Patients treated from 2017 to 2024 with aortic arch repair using double-fenestrated physician-modified endografts (PMEGs) for cTAAD were retrospectively analyzed. The objectives are to compare aortic treatment and remodeling, SAT evolution, and overall outcomes according to SAT dissection status (before and after), total aortic arch repair using a double-fenestrated PMEG. Results: Among 42 cTAAD patients treated, 30 had SAT dissection. Thirty-five patients received a standard PMEG, while 7 underwent additional selective SAT stenting (3 LCCA, 1 brachiocephalic trunk (BT), 4 right subclavian artery (RSA), and 3 right common carotid artery (RCCA)). Technical success was 100%. At 30 days, 1 patient died from stroke, 1 from pneumonia post-discharge. During a median follow-up of 18.5 months (IQR: 38.8), no type Ia endoleaks occurred. Six type Ic endoleaks were observed; 3 patients underwent reintervention, while the remaining 3 were monitored with follow-up CT scans showing no evidence of aortic growth. Complete SAT dissection resolution occurred in 12 patients (40%), including 9 with standard PMEG. Positive aortic remodeling was seen in 32 patients (76%) with a median diameter reduction of −1% (IQR: 5.5%). Five patients died during mid-term follow-up, with no deaths related to the procedure. Positive aortic remodeling rates are 73% vs. 83% (p=0.7) between patients with and without initial SAT dissection, 83% vs 92% (p=1) between patients with initially no SAT dissection and those who healed, 61% vs 88% (p=0.07) between patients with persistent SAT dissection and the others. Patients on curative anticoagulation or dual antiplatelet therapy showed reduced positive remodeling. Conclusion: Double-fenestrated PMEGs are effective for treating residual cTAADs, with high SAT healing and favorable remodeling. Persistent SAT dissection may hinder remodeling and require additional intervention. Clinical Impact: Aortic arch repair using fenestrated physician-modified endografts without systematic SAT stenting reduces SAT manipulation and may lower stroke risk, while promoting a high rate of SAT and aortic dissection healing. In cases where SAT dissection persists and aortic growth is reported, secondary complementary SAT intervention can be performed to enhance aortic remodeling.